Skip to content

Home
About the Company
Investment Philosophy
Contact

Regulatory Filings

Includes mandatory disclosures submitted to NSE/BSE and SEBI such as shareholding patterns, compliance reports, annual filings, and insider trading disclosures.

Sapphire Foods Receives GST Show Cause Notices Aggregating ₹97.71 Crore from Tamil Nadu Tax Authorities

27/05/2026 / Regulatory Filings / Regulatory / Tax Notice

Sapphire Foods Receives GST Show Cause Notices Aggregating ₹97.71 Crore from Tamil Nadu Tax Authorities Read Post »

MobiKwik receives RBI in-principle approval for Offline Payment Aggregator license; targets 10x merchant business growth by FY28

26/05/2026 / Regulatory Filings / Regulatory Approval

MobiKwik receives RBI in-principle approval for Offline Payment Aggregator license; targets 10x merchant business growth by FY28 Read Post »

Gujarat High Court Rejects Tata Chemicals’ Legacy Wastewater Channel Claim; Environmental Assessment Ordered

26/05/2026 / Regulatory Filings / Regulatory / Legal Development

Gujarat High Court Rejects Tata Chemicals’ Legacy Wastewater Channel Claim; Environmental Assessment Ordered Read Post »

Kalyani Steels submits FY2026 Annual Secretarial Compliance Report; reports board composition non-compliance and SEBI settlement update

25/05/2026 / Regulatory Filings / SEBI Regulatory Compliance Filing

Kalyani Steels submits FY2026 Annual Secretarial Compliance Report; reports board composition non-compliance and SEBI settlement update Read Post »

US FDA Classifies Eugia Pharma’s Telangana Facility as OAI Following February 2026 Inspection

25/05/2026 / Regulatory Filings / Regulatory Compliance Update

US FDA Classifies Eugia Pharma’s Telangana Facility as OAI Following February 2026 Inspection Read Post »

Jubilant Pharmova Subsidiary Receives ₹107.89 Crore Income Tax Adjustment Order for FY23

24/05/2026 / Regulatory Filings / Regulatory / Tax Litigation

Jubilant Pharmova Subsidiary Receives ₹107.89 Crore Income Tax Adjustment Order for FY23 Read Post »

Welspun Enterprises Subsidiary Receives GST Show Cause Notices of ₹179.87 Crore from Tamil Nadu Authority

23/05/2026 / Regulatory Filings / Regulatory / Tax Litigation

Welspun Enterprises Subsidiary Receives GST Show Cause Notices of ₹179.87 Crore from Tamil Nadu Authority Read Post »

Venus Remedies Receives Saudi FDA Approval for Plerixafor; Marks First Global Specialty Oncology Authorization

22/05/2026 / Regulatory Filings / International Regulatory Approval

Venus Remedies Receives Saudi FDA Approval for Plerixafor; Marks First Global Specialty Oncology Authorization Read Post »

Alembic Pharmaceuticals Receives USFDA Final Approval for Levothyroxine Sodium Tablets Across Multiple Strengths

22/05/2026 / Regulatory Filings / Regulatory Approval (ANDA)

Alembic Pharmaceuticals Receives USFDA Final Approval for Levothyroxine Sodium Tablets Across Multiple Strengths Read Post »

Vedanta Discloses Supreme Court Judgment Against Talwandi Sabo Power; ₹127 Crore Liability Impact

22/05/2026 / Regulatory Filings / Regulatory / Legal Development

Vedanta Discloses Supreme Court Judgment Against Talwandi Sabo Power; ₹127 Crore Liability Impact Read Post »

← Previous 1 2 3 4 … 11 Next →

Search Insights

Categories

Business Updates
Corporate Actions
Financial Results
Fundraising
General Announcements
Investment Strategy
Investor Communication
Management Changes
Market Insights
Material Events
Operations & Projects
Order Wins & Contracts
Quarterly Results
Regulatory Filings

Home
About the Company
Investment Philosophy
Contact

Terms & Conditions
Privacy Policy
Disclaimer
Editorial Policy
Data Sources
Copyright Notice

Copyright © 2026 Innovacia Insights

Scroll to Top